儿童二甲双胍暴露的临床结局:美国国家毒物数据系统分析
该研究利用美国国家毒物数据系统®分析了2011至2021年间6岁以下儿童单剂二甲双胍暴露的临床过程、结局和按mg/kg计算的剂量。共纳入8762例暴露,其中74.1%在非医疗场所管理,3.4%收入重症监护。在1270例有mg/kg数据的患者中,85.1%为≤85 mg/kg的安全组,14.9%为>85 mg/kg的警示组。警示组住院率(6%)是安全组(0.6%)的十倍。作者认为大多数探索性儿童单剂二甲双胍暴露是安全的,可在家管理,≤85 mg/kg阈值可识别预期结局良好、几乎无需医疗管理的暴露。
要点
- 6岁以下儿童单剂二甲双胍暴露中,74.1%在非医疗场所管理,仅2.5%需要住院。
- 有mg/kg数据的1270例中,≤85 mg/kg安全组占85.1%,>85 mg/kg警示组占14.9%。
- 警示组(>85 mg/kg)住院率为6%,安全组(≤85 mg/kg)为0.6%,前者是后者的十倍。
- 重症监护入院占全部8762例暴露的3.4%。
- 作者结论认为≤85 mg/kg阈值可识别预期结局良好、几乎无需医疗管理的暴露。
适用人群与场景
- 6岁以下儿童单剂二甲双胍暴露,数据来自美国国家毒物数据系统®2011至2021年记录。
- 按报告剂量分为安全组(≤85 mg/kg,可在家管理)和警示组(>85 mg/kg,应送往医疗机构)。
诊断标准与关键阈值
- 安全组:报告剂量≤85 mg/kg,可在家管理。
- 警示组:报告剂量>85 mg/kg,应送往医疗机构。
研究设计与关键结果
- 研究类型为利用美国国家毒物数据系统®的回顾性分析,纳入2011至2021年6岁以下儿童单剂二甲双胍暴露8762例。
- 6493例(74.1%)在非医疗场所管理,73例(3.4%)收入重症监护。
- 1270例(14.5%)有mg/kg数据,其中1081例(85.1%)为≤85 mg/kg安全组,189例(14.9%)为>85 mg/kg警示组。
- 在有随访信息的病例中,仅2.5%需要住院;警示组住院率6%,安全组0.6%,警示组是安全组的十倍。
证据类型、等级与局限
- 证据类型:基于美国国家毒物数据系统®的回顾性分析。
- 局限:59.4%的病例缺失随访信息。
对床旁实践的改变
- 作者认为大多数探索性儿童单剂二甲双胍暴露是安全的,可在家管理。
- 作者认为≤85 mg/kg阈值可识别预期结局良好、几乎无需医疗管理的暴露。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Prior studies suggest metformin exposures in young pediatric patients are low risk, and a triage threshold of 85 mg/kg can be used to reduce unnecessary evaluations. Our objective was to analyze single-substance metformin exposures using the National Poison Data System® to describe the clinical course, outcome, and mg/kg dose of metformin exposures in children under six years old. The secondary objective was to describe outcomes in patients divided into safe (≤85 mg/kg reported dose) and caution (>85 mg/kg reported dose) categories.
METHODS: Using the National Poison Data System®, we analyzed single-substance metformin exposures from 2011-2021 in patients under six years old. We defined two categories of metformin overdose patients: safe (≤85 mg/kg reported dose), who could be managed at home, and caution (>85 mg/kg reported dose), who should be sent to a healthcare facility. Data were summarized with medians with interquartile ranges for continuous variables and percentages for categorical variables.
RESULTS: There were 8,762 single-substance metformin exposures reported from 2011-2021. Most patients (6,493, 74.1%) were managed in a non-healthcare setting. Critical care admissions accounted for 73 (3.4%) exposures. For the 1,270 (14.5%) patients who had mg/kg data available, 1,081 (85.1%) were in the safe category with ingestions ≤85 mg/kg, while 189 (14.9%) were in the caution category with ingestions >85 mg/kg.
DISCUSSION: Data were limited due to 59.4% of cases missing follow-up information. However, in patients with follow-up information available, most cases were managed on site (74.1%) and only 2.5% of cases required hospitalization. Caution range patients had ten times more admissions (6%) than safe range patients (0.6%).
CONCLUSION: Most exploratory pediatric single-agent metformin exposures were safe and could be managed at home. The ≤85 mg/kg threshold identifies exposures with expected good outcome requiring little to no medical management.
参考来源
- Shafer S, Stuteville H, Varney SM, et al. Clinical outcomes of pediatric metformin exposures reported to the National Poison Data System®. Clin Toxicol (Phila). 2025. PMID: 41294078. doi:10.1080/15563650.2025.2587773
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。